Purchase Agreements in the Biotechnology Industry

2,647 Contracts & Agreements

Browse by Company

AbbVie Inc. (1 contract)
ABEONA THERAPEUTICS INC. (8)
Achaogen, Inc. (2)
ACHIEVE LIFE SCIENCES, INC. (11)
Acorda Therapeutics (7)
Actinium Pharmaceuticals, Inc. (4)
Acurx Pharmaceuticals, LLC (5)
Adamas Pharmaceuticals Inc (2)
Adaptimmune Therapeutics PLC (2)
Adhera Therapeutics, Inc. (29)
ADiTx Therapeutics, Inc. (21)
ADMA BIOLOGICS, INC. (5)
ADURO BIOTECH, INC. (1)
Advaxis, Inc. (12)
Adverum Biotechnologies, Inc. (1)
Aeglea BioTherapeutics, Inc. (9)
AGENUS INC (11)
AGIOS PHARMACEUTICALS INC (3)
AILERON THERAPEUTICS INC (3)
Aimmune Therapeutics, Inc. (3)
Akero Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (4)
Aldeyra Therapeutics, Inc. (2)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (1)
Alkermes plc. (3)
Allarity Therapeutics, Inc. (10)
Allena Pharmaceuticals, Inc. (4)
Alliqua BioMedical, Inc. (17)
Allovir, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (3)
Alpha Healthcare Acquisition Corp. (3)
ALPINE IMMUNE SCIENCES, INC. (3)
Altimmune, Inc. (7)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (6)
AMARIN CORP PLC (3)
AMERICAN CRYOSTEM Corp (1)
Amgen Inc. (11)
AMICUS THERAPEUTICS, INC. (2)
AmpliPhi Biosciences Corp (8)
Amplitude Healthcare Acquisition Corp (2)
ANAPTYSBIO INC (1)
ANAVEX LIFE SCIENCES CORP. (8)
Anchiano Therapeutics Ltd. (2)
Anika Therapeutics (1)
Anixa Biosciences Inc (1)
Annexon, Inc. (1)
Annovis Bio, Inc. (2)
Apellis Pharmaceuticals, Inc. (2)
Applied Therapeutics Inc. (3)
Aprea Therapeutics, Inc. (1)
Aptevo Therapeutics Inc. (11)
AquaBounty Technologies, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (3)
Aravive, Inc. (6)
Arbutus Biopharma Corp (1)
ARCA biopharma, Inc. (2)
Arcturus Therapeutics Holdings Inc. (4)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (2)
ARENA PHARMACEUTICALS INC (4)
Aridis Pharmaceuticals, Inc. (8)
ARROWHEAD PHARMACEUTICALS, INC. (9)
Arsanis, Inc. (6)
ARYA Sciences Acquisition Corp II (2)
ASSEMBLY BIOSCIENCES, INC. (2)
Atara Biotherapeutics, Inc. (3)
Athenex, Inc. (4)
ATHERSYS, INC (13)
ATOSSA GENETICS INC (4)
Atreca, Inc. (1)
aTYR PHARMA INC (3)
AVEO PHARMACEUTICALS INC (4)
Avid Bioservices, Inc. (2)
Avidity Biosciences, Inc. (2)
Axcella Health Inc. (4)
Axovant Sciences Ltd. (1)
Ayala Pharmaceuticals, Inc. (1)
AZIYO BIOLOGICS, INC. (3)
AzurRx BioPharma, Inc. (13)
BAKKEN RESOURCES INC (1)
BCTG Acquisition Corp. (1)
Beam Therapeutics Inc. (1)
BELLICUM PHARMACEUTICALS, INC (5)
Big Cypress Acquisition Corp. (5)
BIO-PATH HOLDINGS INC (13)
bioAffinity Technologies, Inc. (2)
BioCardia, Inc. (7)
BIOCEPT INC (7)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (1)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BIOMARIN PHARMACEUTICAL INC (10)
BioNexus Gene Lab Coporation (1)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (1)
Biostage, Inc. (17)
BIOTIME INC (5)
BIOVIE INC. (8)
BioXcel Therapeutics, Inc. (2)
BIOXYTRAN, INC (18)
Bison Capital Acquisition Corp. (4)
Blue Water Vaccines Inc. (6)
bluebird bio, Inc. (7)
Blueprint Medicines Corp (2)
Bone Biologics Corp (6)
BRAINSTORM CELL THERAPEUTICS INC. (4)
BridgeBio Pharma, Inc. (5)
BullFrog AI Holdings, Inc. (1)
CALADRIUS BIOSCIENCES, INC. (19)
Calithera Biosciences, Inc. (2)
Calyxt, Inc. (2)
CANCER GENETICS, INC (13)
CAPRICOR THERAPEUTICS, INC. (5)
Capstone Therapeutics Corp. (2)
CareDx, Inc. (6)
CASI Pharmaceuticals, Inc. (5)
CASTLE BIOSCIENCES INC (2)
CATALYST BIOSCIENCES, INC. (9)
CATALYST PHARMACEUTICALS, INC. (6)
CEL SCI CORP (15)
Celcuity Inc. (3)
Celldex Therapeutics, Inc. (3)
Cellectar Biosciences, Inc. (12)
Cellular Biomedicine Group, Inc. (10)
Celsion CORP (22)
Century Therapeutics, Inc. (2)
CEREBAIN BIOTECH CORP. (5)
Chanticleer Holdings, Inc. (10)
Chardan Healthcare Acquisition Corp. (4)
Checkpoint Therapeutics, Inc. (6)
Chelsea Worldwide Inc. (2)
CHIMERIX INC (2)
Cibus Global, Ltd. (1)
Cidara Therapeutics, Inc. (2)
CLEVELAND BIOLABS INC (16)
Clovis Oncology, Inc. (2)
CM Life Sciences III Inc. (5)
CohBar, Inc. (1)
Coherus BioSciences, Inc. (1)
Comera Life Sciences Holdings, Inc. (4)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (7)
CONCERT PHARMACEUTICALS, INC. (3)
Consonance-HFW Acquisition Corp. (3)
Constellation Alpha Capital Corp. (2)
CONSTELLATION PHARMACEUTICALS INC (1)
CONTRAFECT Corp (5)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (13)
Crinetics Pharmaceuticals, Inc. (1)
CTD HOLDINGS INC (11)
CTI BIOPHARMA CORP (34)
Cue Biopharma, Inc. (4)
Curative Biotechnology Inc (5)
CURIS INC (4)
Cyclacel Pharmaceuticals, Inc. (9)
Cyclerion Therapeutics, Inc. (1)
CytoDyn Inc. (17)
Cytokinetics, Incorporated (5)
CytomX Therapeutics, Inc. (1)
CYTORI THERAPEUTICS, INC. (14)
CYTRX CORP (10)
DelMar Pharmaceuticals, Inc. (8)
Denali Therapeutics Inc. (1)
Dermavant Sciences Ltd (3)
DiaMedica Therapeutics Inc. (2)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (8)
Digital Development Partners, Inc. (16)
DYADIC INTERNATIONAL INC (2)
Dynamics Special Purpose Corp. (2)
Eagle Pharmaceuticals, Inc. (3)
Eiger BioPharmaceuticals, Inc. (7)
Elevation Oncology, Inc. (1)
Eliem Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (15)
Emergent BioSolutions Inc. (3)
Enanta Pharmaceuticals, Inc. (1)
ENDONOVO THERAPEUTICS, INC. (8)
Enochian Biosciences Inc (4)
Entasis Therapeutics Holdings Inc. (4)
Entera Bio Ltd. (1)
Environmental Impact Acquisition Corp (2)
ENZON PHARMACEUTICALS, INC. (1)
Epizyme, Inc. (1)
Equillium, Inc. (2)
Erasca, Inc. (1)
Esperion Therapeutics, Inc. (5)
Evelo Biosciences, Inc. (2)
EVOLUTIONARY GENOMICS, INC. (1)
EXACT SCIENCES CORP (3)
Exelixis (3)
EXICURE, INC. (4)
FATE THERAPEUTICS INC (3)
FENNEC PHARMACEUTICALS INC. (3)
Fibrocell Science, Inc. (8)
Finch Therapeutics Group, Inc. (1)
Flex Pharma, Inc. (3)
FLUOROPHARMA MEDICAL, INC. (3)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (8)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (1)
Fusion Pharmaceuticals Inc. (9)
Gain Therapeutics, Inc. (1)
GALECTIN THERAPEUTICS INC (10)
Galera Therapeutics, Inc. (3)
Gemphire Therapeutics Inc. (5)
Gene Biotherapeutics, Inc. (14)
GENELUX CORP (2)
GENEREX BIOTECHNOLOGY CORP (17)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (10)
GeoVax Labs, Inc. (13)
Gossamer Bio, Inc. (1)
Greater Cannabis Company, Inc. (7)
Gritstone Oncology, Inc. (4)
GT Biopharma, Inc. (19)
GTX INC (7)
GX Acquisition Corp. (9)
HALOZYME THERAPEUTICS INC (3)
HARBOR DIVERSIFIED, INC. (10)
Harpoon Therapeutics, Inc. (2)
HCW Biologics Inc. (1)
Health Sciences Acquisitions Corp (3)
HEAT BIOLOGICS, INC. (1)
HedgePath Pharmaceuticals, Inc. (9)
HEMISPHERX BIOPHARMA INC (13)
HERON THERAPEUTICS, INC. (6)
HISTOGENICS CORP (10)
Homology Medicines, Inc. (3)
HST Global, Inc. (1)
HUMANIGEN, INC (5)
iBio, Inc. (12)
Icosavax, Inc. (1)
IDERA PHARMACEUTICALS, INC. (7)
Imago BioSciences, Inc. (1)
Immix Biopharma, Inc. (1)
IMMUCELL CORP (4)
IMMUNE PHARMACEUTICALS INC (24)
Immune Therapeutics, Inc. (2)
ImmunoCellular Therapeutics, Ltd. (3)
IMMUNOGEN INC (3)
Immunome Inc. (3)
IMPEL NEUROPHARMA INC (1)
IN8BIO, INC. (1)
INFINITY PHARMACEUTICALS, INC. (4)
Inhibikase Therapeutics, Inc. (2)
Inhibrx, Inc. (1)
InMed Pharmaceuticals Inc. (8)
Inmune Bio, Inc. (6)
Innovation Pharmaceuticals Inc. (5)
INOVIO PHARMACEUTICALS, INC. (3)
Inozyme Pharma, Inc. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (8)
Intec Parent Inc. (3)
Intec Pharma Ltd. (4)
INTERCEPT PHARMACEUTICALS, INC. (2)
International Stem Cell CORP (11)
INTREXON CORP (4)
Intrinsic Medicine, Inc. (1)
Invitae Corp (4)
IO Biotech, Inc. (1)
IONIS PHARMACEUTICALS INC (2)
IOVANCE BIOTHERAPEUTICS, INC. (4)
IRONWOOD PHARMACEUTICALS INC (1)
Isoray, Inc. (9)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (5)
Karyopharm Therapeutics Inc. (3)
KBL MERGER CORP. IV (10)
Kindred Biosciences, Inc. (1)
Kiniksa Pharmaceuticals, Ltd. (1)
Kinnate Biopharma Inc. (1)
Kiromic Biopharma, Inc. (2)
KIWA BIO-TECH PRODUCTS GROUP CORP (5)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (3)
Kura Oncology, Inc. (4)
Kymera Therapeutics, Inc. (1)
LA JOLLA PHARMACEUTICAL CO (4)
LEAP THERAPEUTICS, INC. (4)
Leisure Acquisition Corp. (11)
LEXICON PHARMACEUTICALS, INC. (15)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (6)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (4)
Locust Walk Acquisition Corp. (4)
LONGEVERON LLC (5)
MACROGENICS INC (2)
MADRIGAL PHARMACEUTICALS, INC. (3)
Magenta Therapeutics, Inc. (2)
MAIA Biotechnology, Inc. (2)
MANHATTAN SCIENTIFICS INC (4)
MANNKIND CORP (2)
MARIZYME INC (14)
Marker Therapeutics, Inc. (10)
MATEON THERAPEUTICS INC (22)
Matinas BioPharma Holdings, Inc. (2)
MEDICINOVA INC (2)
Medovex Corp. (19)
MEI Pharma, Inc. (4)
MeiraGTx Holdings plc (2)
MERRIMACK PHARMACEUTICALS INC (4)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (3)
Minerva Neurosciences, Inc. (3)
MIRAGEN THERAPEUTICS, INC. (3)
Mirum Pharmaceuticals, Inc. (3)
Molecular Templates, Inc. (6)
Moleculin Biotech, Inc. (6)
Momenta Pharmaceuticals, Inc. (4)
Monte Rosa Therapeutics, Inc. (1)
Morphic Holding, Inc. (1)
MUSTANG BIO, INC. (6)
Myovant Sciences Ltd. (4)
NANOVIRICIDES, INC. (7)
NantKwest, Inc. (7)
NAVIDEA BIOPHARMACEUTICALS, INC. (9)
NEUROBIOLOGICAL TECHNOLOGIES INC (4)
NEUROTROPE BIOSCIENCE, INC. (4)
Neurotrope, Inc. (4)
NEWLINK GENETICS CORP (2)
NexImmune, Inc. (1)
NORTHWEST BIOTHERAPEUTICS INC (7)
NOVAVAX INC (13)
Novus Therapeutics, Inc. (1)
NTN BUZZTIME INC (13)
Nuo Therapeutics, Inc. (11)
Nurix Therapeutics, Inc. (1)
Nuvectis Pharma, Inc. (1)
Ohr Pharmaceutical Inc (9)
Olivia Ventures, Inc. (1)
Omega Therapeutics, Inc. (1)
OncBioMune Pharmaceuticals, Inc (24)
OncoCyte Corp (9)
ONCOSEC MEDICAL Inc (24)
OPGEN INC (13)
Ophthotech Corp. (1)
Opko Health, Inc. (8)
ORAGENICS INC (10)
Orchard Therapeutics plc (2)
Organicell Regenerative Medicine, Inc. (6)
Organogenesis Holdings Inc. (3)
Orgenesis Inc. (14)
Oric Pharmaceuticals, Inc. (1)
Outlook Therapeutics, Inc. (14)
PALATIN TECHNOLOGIES INC (8)
Pasithea Therapeutics Corp. (4)
PDL BIOPHARMA, INC. (6)
Petra Acquisition Inc. (9)
PharmaCyte Biotech, Inc. (7)
PhaseBio Pharmaceuticals Inc (1)
Phio Pharmaceuticals Corp. (17)
PIERIS PHARMACEUTICALS, INC. (3)
PLURISTEM THERAPEUTICS INC (7)
POLARITYTE, INC. (21)
PORTOLA PHARMACEUTICALS INC (2)
Poseida Therapeutics, Inc. (2)
PRECISION BIOSCIENCES INC (2)
PREDICTIVE TECHNOLOGY GROUP, INC. (4)
Prelude Therapeutics Inc (1)
PREMIER BIOMEDICAL INC (14)
Progenics Pharmaceuticals, Inc. (1)
PROGENITY, INC. (7)
ProMIS Neurosciences Inc. (3)
Propanc Biopharma, Inc. (73)
Protagenic Therapeutics, Inc. (5)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (1)
PROTEOSTASIS THERAPEUTICS, INC. (10)
Prothena Corp plc (1)
PTC THERAPEUTICS, INC. (4)
PUMA BIOTECHNOLOGY, INC. (4)
Pyxis Oncology, Inc. (1)
Q BioMed Inc. (21)
Radius Health, Inc. (1)
Rallybio Corp (1)
RAPT Therapeutics, Inc. (1)
Rasna Therapeutics Inc. (2)
REGENERX BIOPHARMACEUTICALS INC (12)
REGENXBIO Inc. (1)
Regulus Therapeutics Inc. (3)
Relay Therapeutics, Inc. (1)
Reneo Pharmaceuticals, Inc. (1)
RenovaCare, Inc. (3)
RenovoRx, Inc. (1)
Retrophin, Inc. (16)
REXAHN PHARMACEUTICALS, INC. (28)
Rezolute, Inc. (11)
RHYTHM PHARMACEUTICALS, INC. (1)
Rich Pharmaceuticals, Inc. (16)
RIGEL PHARMACEUTICALS INC (5)
RITTER PHARMACEUTICALS INC (12)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (2)
SANGAMO THERAPEUTICS, INC (2)
Sarepta Therapeutics, Inc. (10)
Savara Inc (8)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (3)
SELECTA BIOSCIENCES INC (3)
SELLAS Life Sciences Group, Inc. (18)
Sensei Biotherapeutics, Inc. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (4)
Shattuck Labs, Inc. (1)
Shuttle Pharmaceuticals Holdings, Inc. (3)
Sierra Oncology, Inc. (3)
Social Capital Suvretta Holdings Corp. III (4)
SOLENO THERAPEUTICS INC (12)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (15)
SOPHIRIS BIO INC. (5)
Sorrento Therapeutics, Inc. (11)
Spectrum Pharmaceuticals, Inc. (11)
Spero Therapeutics, Inc. (2)
SPHERIX INC (29)
Spinning Eagle Acquisition Corp. (5)
Spring Bank Pharmaceuticals, Inc. (1)
SpringWorks Therapeutics, Inc. (1)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (1)
Stellar Biotechnologies, Inc. (5)
Summit Therapeutics Inc. (4)
Sun BioPharma, Inc. (14)
SUNESIS PHARMACEUTICALS INC (2)
Sunshine Biopharma, Inc (7)
SUTRO BIOPHARMA, INC. (1)
Syndax Pharmaceuticals Inc (4)
Synthetic Biologics, Inc. (5)
Syros Pharmaceuticals, Inc. (4)
T2 Biosystems, Inc. (3)
Taysha Gene Therapies, Inc. (2)
TENAX THERAPEUTICS, INC. (17)
TG THERAPEUTICS, INC. (1)
Therapeutics Acquisition Corp. (2)
Tocagen Inc (1)
Tonix Pharmaceuticals Holding Corp. (22)
Tracon Pharmaceuticals, Inc. (2)
Transcode Therapeutics, Inc. (7)
Translate Bio, Inc. (4)
TREVENA INC (5)
Trovagene, Inc. (18)
TYME TECHNOLOGIES, INC. (2)
Tyra Biosciences, Inc. (1)
U.S. Stem Cell, Inc. (9)
Ultragenyx Pharmaceutical Inc. (4)
Unicycive Therapeutics, Inc. (5)
uniQure N.V. (2)
United Therapeutics Corp (13)
Unity Biotechnology, Inc. (1)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (1)
USA EQUITIES CORP. (3)
VACCINEX, INC. (8)
Vanda Pharmaceuticals Inc. (1)
Vaxart, Inc. (12)
VBI Vaccines Inc (1)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (3)
Verastem, Inc. (4)
Vericel Corp (2)
Vertex Pharmaceuticals Inc (3)
VICAL INC (8)
Vicapsys Life Sciences, Inc. (1)
Viela Bio, Inc. (4)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (3)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (8)
VITAL THERAPIES INC (8)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (1)
vTv Therapeutics Inc. (3)
WINDTREE THERAPEUTICS INC (11)
XBiotech Inc. (2)
Xencor Inc (2)
Xenetic Biosciences, Inc. (6)
Xenon Pharmaceuticals Inc. (1)
Xilio Therapeutics, Inc. (1)
XOMA Corp (11)
Y-mAbs Therapeutics, Inc. (1)
YIELD10 BIOSCIENCE, INC. (12)
ZIOPHARM ONCOLOGY INC (3)

Recent Contracts

Form of Securities Purchase Agreement (Biostage, Inc., Filed With SEC on April 17, 2024)
Securities Purchase Agreement, dated April 10, 2024, between the Company and the purchasers party thereto (Aptevo Therapeutics Inc., Filed With SEC on April 15, 2024)
Securities Purchase Agreement, dated April 11, 2024, by and among the Company and the investors signatory thereto (OncoCyte Corp, Filed With SEC on April 12, 2024)
Form of Securities Purchase Agreement (VBI Vaccines Inc, Filed With SEC on April 11, 2024)
Securities Purchase Agreement, dated April 11, 2024, by and among the Company and the other parties thereto (Century Therapeutics, Inc., Filed With SEC on April 11, 2024)
Securities Purchase Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto (Eliem Therapeutics, Inc., Filed With SEC on April 11, 2024)
Form of Securities Purchase Agreement, dated April 8, 2024, by and between the Company and the Purchasers signatory thereto (LONGEVERON LLC, Filed With SEC on April 11, 2024)
Form of Securities Purchase Agreement by and among the Company and the purchasers named therein (LEAP THERAPEUTICS, INC., Filed With SEC on April 11, 2024)
Asset Purchase and Strategic Collaboration Agreement, dated as of April 5, 2024, between Orgenesis Maryland LLC and Griffin Fund 3 BIDCO, Inc (Orgenesis Inc., Filed With SEC on April 11, 2024)
Form of Securities Purchase Agreement by and between Windtree Therapeutics, Inc. and the Buyers named therein, dated April 2, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 8, 2024)
Form of Asset Purchase Agreement by and between Windtree Therapeutics, Inc. and Varian Biopharmaceuticals, Inc., dated April 2, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 8, 2024)
Form of Securities Purchase Agreement (Matinas BioPharma Holdings, Inc., Filed With SEC on April 5, 2024)
First Amendment to the Asset Purchase Agreement (ATHERSYS, INC, Filed With SEC on April 5, 2024)
Amendment No. 1 to Asset Purchase Agreement, dated March 28, 2024, by and among Isoray Medical, Inc., GT Medical Technologies, Inc., and Perspective Therapeutics, Inc (Isoray, Inc., Filed With SEC on April 3, 2024)
Form of Securities Purchase Agreement (LONGEVERON LLC, Filed With SEC on April 3, 2024)
Form of Securities Purchase Agreement, dated April 1, 2024, by and among Surrozen, Inc. and each of the several purchasers signatory thereto (Consonance-HFW Acquisition Corp., Filed With SEC on April 2, 2024)
Form of Securities Purchase Agreement (MUSTANG BIO, INC., Filed With SEC on April 2, 2024)
Form of Voting Agreement (attached as Exhibit D to the Form of Securities Purchase Agreement) (PROGENITY, INC., Filed With SEC on April 2, 2024)
Atlas Equity Purchase Agreement (HEMISPHERX BIOPHARMA INC, Filed With SEC on April 1, 2024)
Form of Securities Purchase Agreement, dated March 26, 2024, by and between iBio, Inc. and the Purchaser signatory thereto (iBio, Inc., Filed With SEC on April 1, 2024)
Asset Purchase Agreement, dated March 31, 2024, by and between Sentynl Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc (Eiger BioPharmaceuticals, Inc., Filed With SEC on April 1, 2024)
Securities Purchase Agreement, by and between the Company and Alzheimers Drug Discovery Foundation, dated as of March 29, 2024 (VACCINEX, INC., Filed With SEC on April 1, 2024)
Form of Securities Purchase Agreement for the Additional Private Placement, by and between the Company and each purchaser identified on the signature pages thereto, dated as of... (VACCINEX, INC., Filed With SEC on April 1, 2024)
Form of Securities Purchase Agreement for the AGP Transactions, by and between the Company and each purchaser identified on the signature pages thereto, dated as of March 27, 2024 (VACCINEX, INC., Filed With SEC on April 1, 2024)
Asset Purchase Agreement, dated as of March 27, 2024 by and among BioReference Health, LLC, OPKO Health, Inc. and Laboratory Corporation of America Holdings (Opko Health, Inc., Filed With SEC on March 28, 2024)
Asset Purchase Agreement, dated as of March 27, 2024 by and among BioReference Health, LLC, OPKO Health, Inc. and Laboratory Corporation of America Holdings (Opko Health, Inc., Filed With SEC on March 28, 2024)
Securities Purchase Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto (Xilio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Asset Purchase Agreement dated December 22, 2023, by and between the Registrant and Atreca, Inc (Immunome Inc., Filed With SEC on March 28, 2024)
Amended and Restated Securities Purchase Agreement dated March 28, 2024 (Molecular Templates, Inc., Filed With SEC on March 28, 2024)
Securities Purchase Agreement, dated March 28, 2024, by and between CervoMed Inc. and each of the purchasers party thereto (Diffusion Pharmaceuticals Inc., Filed With SEC on March 28, 2024)
Form of Securities Purchase Agreement (MAIA Biotechnology, Inc., Filed With SEC on March 26, 2024)
Form of Securities Purchase Agreement (BIO-PATH HOLDINGS INC, Filed With SEC on March 26, 2024)
Securities Purchase Agreement, dated March 25, 2024, between the Company and the Purchasers (BioXcel Therapeutics, Inc., Filed With SEC on March 25, 2024)
Form of Securities Purchase Agreement, dated March 21, 2024 by and among Sangamo Therapeutics, Inc. and the purchasers party thereto (SANGAMO THERAPEUTICS, INC, Filed With SEC on March 25, 2024)
Securities Purchase Agreement between Bioxytran, Inc. and Lender, dated March 15, 2024 (BIOXYTRAN, INC, Filed With SEC on March 22, 2024)
Securities Purchase Agreement, dated March 21, 2024 (Annovis Bio, Inc., Filed With SEC on March 21, 2024)
Securities Purchase Agreement, dated as of March 19, 2024, between Fate Therapeutics, Inc. and RedCo II Master Fund, L.P (FATE THERAPEUTICS INC, Filed With SEC on March 21, 2024)
Form of Securities Purchase Agreement (Aptevo Therapeutics Inc., Filed With SEC on March 20, 2024)
Form of Purchase Agreement (Genprex, Inc., Filed With SEC on March 20, 2024)
Revenue Interest Purchase Agreement dated as of December 29, 2023 among ImmunityBio, Inc., the Purchasers from time to time party hereto and Infinity SA LLC (NantKwest, Inc., Filed With SEC on March 19, 2024)